Compounds · Digestive & liver · Tissue healing and gastrointestinal repair
BPC-157
Bepecin, PL 14736, PL-10, Pentadecapeptide BPC 157
Synthetic peptide based on a protective gastric-juice protein, studied in animals for angiogenesis, cellular repair, and cytoprotective/anti-inflammatory effects on tendons, ligaments, gut, and brain. Not FDA-approved, classified as an unapproved drug, and banned by WADA; human evidence is very limited.
0.25–0.5 mg daily
Research score 60/100. Reference only, not a prescription.
- Healing
- Anti-inflammatory
- Gut Health
- Joint Support
- Wound Healing
- Recovery Enhancement
- US status
- Unapproved drug. FDA removed it from the 503A Category 2 list in April 2026 pending advisory-committee review; that does not make it approved or compoundable. Prohibited by WADA.
- Approval
- Not FDA Approved for human or animal use.
- Evidence
- Limited Human Studies
- Research score
- 60 / 100
- Indication
- Research Only - No Medical Indication
- Origin
- Croatia
- Source category
- Digestive System
- Status group
- Research chemical
Mechanism
Raises VEGF-driven blood vessel formation and growth-hormone receptor expression, boosts collagen formation, and activates the FAK-paxillin pathway for cell migration; also promotes nitric oxide release and mucosal defense in the gut.
Safety file
Appears safe in animals with no reported toxicity, but human safety data from controlled trials is lacking; theoretical concern about supporting tumor growth via VEGFR2 activation.
- Injection site reactions (pain, swelling, infection, allergic reactions)
Reconstitution
| Vial | 2 mL water | 3 mL water |
|---|---|---|
| 10 mg | 5 mg/mL | 3.33 mg/mL |
- Use bacteriostatic water as the diluent.
- Add the water slowly, letting it run down the inside wall of the vial rather than onto the powder.
- Swirl gently to mix, then leave it to dissolve. Do not shake.
- Give it a few minutes. The finished solution should be clear and colourless.
Protocol
Route: Subcutaneous
Standard healing protocol (subcutaneous)
- 0.5 mg (500 mcg) per day, the most commonly reported effective dose
- Many split it into 0.25 mg morning and 0.25 mg evening
- For a specific injury, inject near the affected area; for gut or whole-body benefit, any subcutaneous site works
Dosing detail
- Standard daily range is 0.25 mg to 0.5 mg. Start at 0.25 mg for the first week or two, then move to 0.5 mg (often split into two shots) if tolerated.
- Consistency matters more than a big dose. Daily dosing beats occasional larger doses.
- Mild injuries: 2 to 4 weeks. Severe or post-op: 4 to 8 weeks. Do not run past 8 weeks without a break.
- Frequently stacked with TB-500 (the healing or Wolverine stack).
Duration
- Run 4 to 6 weeks for most injuries, up to 8 weeks for severe or post-surgical cases, then take a break before another cycle. Daily, often 5 days on and 2 off.
Notes
- Frequently stacked with TB-500 for soft tissue, tendon and ligament recovery.
- Daily dosing beats sporadic larger doses. Consistency is the main lever.
- Generally very well tolerated.
Storage and handling
- Keep the powdered (lyophilized) vial in a cool, dark place. Refrigerate it for longer-term storage before mixing.
- Once reconstituted and refrigerated at 2–8 °C away from light, use the vial within 28 days.
- Do not freeze a reconstituted vial, and keep it away from heat and sunlight.
- If the solution turns cloudy, develops floating particles, or shows any other sign of degradation, stop using that vial.
NovaEvum vial
Worksheet
Add 2 mL bacteriostatic water down the glass wall. Swirl until the cake is gone. That yields 5 mg/mL, or 50 mcg per insulin unit.
- Catalog fill
- 10 mg
- Typical water
- 2 mL
- Route
- Subcutaneous
- Cycle
- 2–6 weeks of daily use, then a pause at least as long as the run.
| Step | Amount | Frequency | Notes |
|---|---|---|---|
| Common research range | 250 mcg | Once daily | 5 units from a 2 mL reconstitution |
| Upper cited range | 500 mcg | Once daily or split | 10 units from a 2 mL reconstitution |
- Do not shake the vial. Rolling between the palms is enough.
- If the solution clouds or particles remain after swirling, discard it.
- This is a reconstitution worksheet, not a treatment plan.
- Bacteriostatic water: 20–25 °C. Do not refrigerate the diluent.
- Amounts on this sheet are reconstitution math for the vial, not a recommendation.